BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28271909)

  • 1. Challenges in searching for therapeutics against Botulinum Neurotoxins.
    Pirazzini M; Rossetto O
    Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to design inhibitors of Clostridium botulinum neurotoxins.
    Cai S; Singh BR
    Infect Disord Drug Targets; 2007 Mar; 7(1):47-57. PubMed ID: 17346211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies for designing antidotes against botulinum neurotoxins.
    Patel K; Cai S; Singh BR
    Expert Opin Drug Discov; 2014 Mar; 9(3):319-33. PubMed ID: 24520991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based drug discovery for botulinum neurotoxins.
    Swaminathan S
    Curr Top Microbiol Immunol; 2013; 364():197-218. PubMed ID: 23239355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.
    Capková K; Salzameda NT; Janda KD
    Toxicon; 2009 Oct; 54(5):575-82. PubMed ID: 19327377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaining ground: assays for therapeutics against botulinum neurotoxin.
    Hakami RM; Ruthel G; Stahl AM; Bavari S
    Trends Microbiol; 2010 Apr; 18(4):164-72. PubMed ID: 20202845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum Neurotoxins: Mechanism of Action.
    Rossetto O; Pirazzini M; Fabris F; Montecucco C
    Handb Exp Pharmacol; 2021; 263():35-47. PubMed ID: 32277300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.
    Azarnia Tehran D; Zanetti G; Leka O; Lista F; Fillo S; Binz T; Shone CC; Rossetto O; Montecucco C; Paradisi C; Mattarei A; Pirazzini M
    Sci Rep; 2015 Dec; 5():17513. PubMed ID: 26670952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism.
    Zanetti G; Azarnia Tehran D; Pirazzini M; Binz T; Shone CC; Fillo S; Lista F; Rossetto O; Montecucco C
    Biochem Pharmacol; 2015 Dec; 98(3):522-30. PubMed ID: 26449594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery.
    Duplantier AJ; Kane CD; Bavari S
    Curr Top Med Chem; 2016; 16(21):2330-49. PubMed ID: 27072693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of Botulinum Toxins: Challenges and Opportunities for the Future.
    Rasetti-Escargueil C; Lemichez E; Popoff MR
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
    Tehran DA; Pirazzini M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thioredoxin reductase--Thioredoxin redox system cleaves the interchain disulphide bond of botulinum neurotoxins on the cytosolic surface of synaptic vesicles.
    Pirazzini M; Azarnia Tehran D; Zanetti G; Lista F; Binz T; Shone CC; Rossetto O; Montecucco C
    Toxicon; 2015 Dec; 107(Pt A):32-6. PubMed ID: 26130523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.
    Wilson BA; Ho M
    Curr Top Med Chem; 2014; 14(18):2081-93. PubMed ID: 25335885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.
    Rasetti-Escargueil C; Popoff MR
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31547338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
    Cai F; Adrion CB; Keller JE
    Infect Immun; 2006 Oct; 74(10):5617-24. PubMed ID: 16988237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs.
    Barker D; Gillum KT; Niemuth NA; Kodihalli S
    PLoS One; 2019; 14(9):e0222670. PubMed ID: 31527885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.